Published on 19 Jun 2024 on Simply Wall St. · via Yahoo Finance
With the business potentially at an important milestone, we thought we'd take a closer look at Theratechnologies Inc.'s (TSE:TH) future prospects. Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. With the latest financial year loss of US$24m and a trailing-twelve-month loss of US$18m, the CA$78m market-cap company alleviated its loss by moving closer towards its target of breakeven. The most pressing concern for investors is Theratechnologies' path to profitability – when will it breakeven? Below we will provide a high-level summary of the industry analysts’ expectations for the company.
View our latest analysis for Theratechnologies